These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 25101889)

  • 1. Defective PTEN regulation contributes to B cell hyperresponsiveness in systemic lupus erythematosus.
    Wu XN; Ye YX; Niu JW; Li Y; Li X; You X; Chen H; Zhao LD; Zeng XF; Zhang FC; Tang FL; He W; Cao XT; Zhang X; Lipsky PE
    Sci Transl Med; 2014 Jul; 6(246):246ra99. PubMed ID: 25101889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonizing miR-7 suppresses B cell hyperresponsiveness and inhibits lupus development.
    Wang M; Chen H; Qiu J; Yang HX; Zhang CY; Fei YY; Zhao LD; Zhou JX; Wang L; Wu QJ; Zhou YZ; Zhang W; Zhang FC; Zhang X; Lipsky PE
    J Autoimmun; 2020 May; 109():102440. PubMed ID: 32201226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced Tyrosine Phosphatase Activity Underlies Dysregulated B Cell Receptor Signaling and Promotes Survival of Human Lupus B Cells.
    Fleischer SJ; Daridon C; Fleischer V; Lipsky PE; Dörner T
    Arthritis Rheumatol; 2016 May; 68(5):1210-21. PubMed ID: 26713408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of novel microRNA signatures linked to human lupus disease activity and pathogenesis: miR-21 regulates aberrant T cell responses through regulation of PDCD4 expression.
    Stagakis E; Bertsias G; Verginis P; Nakou M; Hatziapostolou M; Kritikos H; Iliopoulos D; Boumpas DT
    Ann Rheum Dis; 2011 Aug; 70(8):1496-506. PubMed ID: 21602271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased microRNA-142-3p/5p expression causes CD4+ T cell activation and B cell hyperstimulation in systemic lupus erythematosus.
    Ding S; Liang Y; Zhao M; Liang G; Long H; Zhao S; Wang Y; Yin H; Zhang P; Zhang Q; Lu Q
    Arthritis Rheum; 2012 Sep; 64(9):2953-63. PubMed ID: 22549634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-21 is increased in active systemic lupus erythematosus patients and contributes to the generation of plasma B cells.
    Nakou M; Papadimitraki ED; Fanouriakis A; Bertsias GK; Choulaki C; Goulidaki N; Sidiropoulos P; Boumpas DT
    Clin Exp Rheumatol; 2013; 31(2):172-9. PubMed ID: 23137515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution and underlying mechanisms of CXCR4 overexpression in patients with systemic lupus erythematosus.
    Zhao LD; Liang D; Wu XN; Li Y; Niu JW; Zhou C; Wang L; Chen H; Zheng WJ; Fei YY; Tang FL; Li YZ; Zhang FC; He W; Cao XT; Zhang X
    Cell Mol Immunol; 2017 Oct; 14(10):842-849. PubMed ID: 27665947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CircIBTK inhibits DNA demethylation and activation of AKT signaling pathway via miR-29b in peripheral blood mononuclear cells in systemic lupus erythematosus.
    Wang X; Zhang C; Wu Z; Chen Y; Shi W
    Arthritis Res Ther; 2018 Jun; 20(1):118. PubMed ID: 29884225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTEN/Akt-p27(kip1) Signaling Promote the BM-MSCs Senescence and Apoptosis in SLE Patients.
    Tan W; Gu Z; Shen B; Jiang J; Meng Y; Da Z; Liu H; Tao T; Cheng C
    J Cell Biochem; 2015 Aug; 116(8):1583-94. PubMed ID: 25649549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Syk phosphorylation leads to overexpression of TRAF6 in peripheral B cells of patients with systemic lupus erythematosus.
    Iwata S; Yamaoka K; Niiro H; Jabbarzadeh-Tabrizi S; Wang SP; Kondo M; Yoshikawa M; Akashi K; Tanaka Y
    Lupus; 2015 Jun; 24(7):695-704. PubMed ID: 25432781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of microRNA-155 increases IL-21 mediated STAT3 signaling and IL-21 production in systemic lupus erythematosus.
    Rasmussen TK; Andersen T; Bak RO; Yiu G; Sørensen CM; Stengaard-Pedersen K; Mikkelsen JG; Utz PJ; Holm CK; Deleuran B
    Arthritis Res Ther; 2015 Jun; 17(1):154. PubMed ID: 26055806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased expression of interleukin-21 receptor on peripheral B lymphocytes in systemic lupus erythematosus.
    Mitoma H; Horiuchi T; Kimoto Y; Tsukamoto H; Uchino A; Tamimoto Y; Miyagi Y; Harada M
    Int J Mol Med; 2005 Oct; 16(4):609-15. PubMed ID: 16142394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-6 is responsible for aberrant B-cell receptor-mediated regulation of RAG expression in systemic lupus erythematosus.
    Hillion S; Garaud S; Devauchelle V; Bordron A; Berthou C; Youinou P; Jamin C
    Immunology; 2007 Nov; 122(3):371-80. PubMed ID: 17608810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TLR9-induced miR-155 and Ets-1 decrease expression of CD1d on B cells in SLE.
    Liu F; Fan H; Ren D; Dong G; Hu E; Ji J; Hou Y
    Eur J Immunol; 2015 Jul; 45(7):1934-45. PubMed ID: 25929465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD40-activated B cells from patients with systemic lupus erythematosus can be modulated by therapeutic immunoglobulins in vitro.
    Néron S; Boire G; Dussault N; Racine C; de Brum-Fernandes AJ; Côté S; Jacques A
    Arch Immunol Ther Exp (Warsz); 2009; 57(6):447-58. PubMed ID: 19866343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased frequency of a unique spleen tyrosine kinase bright memory B cell population in systemic lupus erythematosus.
    Fleischer SJ; Giesecke C; Mei HE; Lipsky PE; Daridon C; Dörner T
    Arthritis Rheumatol; 2014 Dec; 66(12):3424-35. PubMed ID: 25156507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of B cell-stimulating factors by B cells in patients with systemic lupus erythematosus.
    Tanaka Y; Saito K; Shirakawa F; Ota T; Suzuki H; Eto S; Yamashita U
    J Immunol; 1988 Nov; 141(9):3043-9. PubMed ID: 3262675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of miR-633 activated AKT/mTOR pathway by targeting AKT1 in lupus CD4
    Chen S; Wang Y; Qin H; Lin J; Xie L; Chen S; Liang J; Xu J
    Lupus; 2019 Apr; 28(4):510-519. PubMed ID: 30760089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of TLR7 increases CCND3 expression via the downregulation of miR-15b in B cells of systemic lupus erythematosus.
    Ren D; Liu F; Dong G; You M; Ji J; Huang Y; Hou Y; Fan H
    Cell Mol Immunol; 2016 Nov; 13(6):764-775. PubMed ID: 26144250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-Regulated Interleukin-10 Induced by E2F Transcription Factor 2-MicroRNA-17-5p Circuitry in Extrafollicular Effector B Cells Contributes to Autoantibody Production in Systemic Lupus Erythematosus.
    Xu L; Wang L; Shi Y; Deng Y; Oates JC; Kamen DL; Gilkeson GS; Wang F; Zhang M; Tan W; Tsao BP
    Arthritis Rheumatol; 2022 Mar; 74(3):496-507. PubMed ID: 34569195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.